Gene · 488
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The anion channel GPR89 is a tumor-specific dependency in breast cancer. | Nat Commun | 2026 | 42773111 | PubTator, text mining | PubMed |
| β-carotene alleviates PM2.5-induced pulmonary fibrosis via suppression of the Frizzled5-mediated Wnt5a/Ca2+pathway. | Ecotoxicol Environ Saf | 2026 | 42759460 | PubTator, text mining | PubMed |
| Comparative transcriptomics analysis of histone deacetylases, transcription factors, and ion channel genes in human iPSC-cardiomyocytes vs. the adult human heart. | J Precis Med (Amst) | 2026 | 42644057 | PubTator, text mining | PubMed |
| Age-Opposed Rewiring of Upstream Translation-Initiation Pattern Across Different Types of Human Cancers. | OMICS | 2026 | 42610666 | PubTator, text mining | PubMed |
| Secukinumab in Refractory Generalized Darier's Disease with a 40-Year Disease Duration: A Case Report. | Clin Cosmet Investig Dermatol | 2026 | 42610100 | PubTator, text mining | PubMed |
| Failed metabolic adaptation to stress contributes to epidermal cell adhesion defects in Darier disease. | Sci Adv | 2026 | 42555718 | PubTator, text mining | PubMed |
| Markedly improved disease control in Darier disease (ATP2A2-nonsyndromic epidermal differentiation disorder) with ustekinumab versus other biologics: a case series. | Skin Health Dis | 2026 | 42539885 | PubTator, text mining | PubMed |
| SERCA2 gatekeeper role in aortic autophagy: targeting the Ca2+-mTOR axis to prevent aortic dissection. | Acta Pharmacol Sin | 2026 | 42509384 | PubTator, text mining | PubMed |
| A case of ATP2A2-nonsyndromic epidermal differentiation disorder with a novel ATP2A2 variant and schizophrenia. | Eur J Dermatol | 2026 | 42507412 | PubTator, text mining | PubMed |
| When calcium crosstalk turns ferroptotic: the SERCA2-VDAC1 axis in AKI. | Kidney Int | 2026 | 42476679 | PubTator, text mining | PubMed |
| Systematic reanalysis of next-generation sequencing data in 101 neuromuscular disorder families enhances diagnostic yield, reveals intronic variants, and identifies a novel disease gene. | J Neurol | 2026 | 42474733 | PubTator, text mining | PubMed |
| Consensus Recommendations for Management of Darier Disease: A Practical Approach. | Dermatol Ther (Heidelb) | 2026 | 42455252 | PubTator, text mining | PubMed |
| A Cross-Layer Inflammatory Signature Links Residual Inflammatory Risk to Heart Failure Risk in Metabolic Syndrome: Network Mapping and Brown Adipose Transcriptomic Support. | J Inflamm Res | 2026 | 42454156 | PubTator, text mining | PubMed |
| MAM-Localized MANF Counteracts Microinflammatory Stress to Attenuate Mitochondrial Dysfunction and Cataractogenesis in High Myopia. | Adv Sci (Weinh) | 2026 | 42419372 | PubTator, text mining | PubMed |
| Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups. | Ann Rheum Dis | 2026 | 42399125 | PubTator, text mining | PubMed |
| Post-infarction KLHL40-mediated regulation of cardiac sarcomeric integrity and function. | PeerJ | 2026 | 42267082 | PubTator, text mining | PubMed |
| Effect of Anti-IL-23 and Anti-IL-17 Therapy on Darier Disease: A Case Series. | Australas J Dermatol | 2026 | 42265939 | PubTator, text mining | PubMed |
| Darier disease-A review highlighting new insights from the Darier Disease International Task Force. | J Eur Acad Dermatol Venereol | 2026 | 42223188 | PubTator, text mining | PubMed |
| Acrokeratosis verruciformis of Hopf: Genetic, clinicopathologic and therapeutic features (Review). | Med Int (Lond) | 2026 | 42205461 | PubTator, text mining | PubMed |
| Computational dissection of sarco/endoplasmic reticulum Ca²⁺-ATPase 2b C-Terminal extension autoinhibition and its therapeutic potential in Darier's disease. | Comput Biol Chem | 2026 | 42190364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/488/papers